Erratum: Tumor cell associated hyaluronan-cd44 signaling promotes pro-tumor inflammation in breast cancer (Cancers, (2020) 12, 1325, 10.3390/cancers12051325)

Patrice M. Witschen, Thomas S. Chaffee, Nicholas J. Brady, Danielle N. Huggins, Todd P. Knutson, Rebecca S. Larue, Sarah A. Munro, Lyubov Tiegs, James B. McCarthy, Andrew C. Nelson, Kathryn L. Schwertfeger

Research output: Contribution to journalComment/debatepeer-review

Abstract

The authors wish to make the following corrections to this paper [1]. The authors would like to acknowledge Dr. Ali Khammanivong for providing gRNA sequences and guidance during the generation of the CD44 knockout cell lines. The authors would also like to acknowledge the Burroughs Wellcome Fund and the Howard Hughes Medical Institute Medical Research Fellowship program for providing funding for Dr. Witschen. The original “Acknowledgments” is Acknowledgments: The authors would like to thank Douglas Yee (funded by Masonic Cancer Center (MCC) Support Grant, P30-CA077598), and other members of the University of Minnesota Breast Cancer Translational Working Group (BrCa-TWG), for assistance with the cell line and patient Nanostring gene expression experiments. The authors would also like to thank the Elsa Pardee foundation (L.Furcht, Allen-Pardee Professor). And should be replaced with: Acknowledgments: The authors would like to thank Douglas Yee (funded by the Masonic Cancer Center (MCC) Support Grant, P30-CA077598), and other members of the University of Minnesota Breast Cancer Translational Working Group (BrCa-TWG), for assistance with the cell line and patient Nanostring gene expression experiments. The authors would also like to thank the Elsa Pardee foundation (L.Furcht, Allen-Pardee Professor). The authors would like to acknowledge Ali Khammanivong for providing gRNA sequences and guidance during the generation of the CD44 knockout cell lines. The authors would also like to acknowledge the Burroughs Wellcome Fund and the Howard Hughes Medical Institute Medical Research Fellowship program for providing funding for Patrice M. Witschen. The authors would like to apologize for these omissions from the original manuscript. These changes do not affect the scientific results. The manuscript will be updated, and the original will remain online on the article webpage.

Original languageEnglish (US)
Article number2736
Pages (from-to)1-2
Number of pages2
JournalCancers
Volume12
Issue number10
DOIs
StatePublished - Oct 2020

Bibliographical note

Funding Information:
The authors would like to acknowledge Dr. Ali Khammanivong for providing gRNA sequences and guidance during the generation of the CD44 knockout cell lines. The authors would also like to acknowledge the Burroughs Wellcome Fund and the Howard Hughes Medical Institute Medical Research Fellowship program for providing funding for Dr. Witschen. The original “Acknowledgments” is Acknowledgments: The authors would like to thank Douglas Yee (funded by Masonic Cancer Center (MCC) Support Grant, P30-CA077598), and other members of the University of Minnesota Breast Cancer Translational Working Group (BrCa-TWG), for assistance with the cell line and patient Nanostring gene expression experiments. The authors would also like to thank the Elsa Pardee foundation (L.Furcht, Allen-Pardee Professor). And should be replaced with: Acknowledgments: The authors would like to thank Douglas Yee (funded by the Masonic Cancer Center (MCC) Support Grant, P30-CA077598), and other members of the University of Minnesota Breast Cancer Translational Working Group (BrCa-TWG), for assistance with the cell line and patient Nanostring gene expression experiments. The authors would also like to thank the Elsa Pardee foundation (L.Furcht, Allen-Pardee Professor). The authors would like to acknowledge Ali Khammanivong for providing gRNA sequences and guidance during the generation of the CD44 knockout cell lines. The authors would also like to acknowledge the Burroughs Wellcome Fund and the Howard Hughes Medical Institute Medical Research Fellowship program for providing funding for Patrice M. Witschen.

Publisher Copyright:
© 2020 by the authors. Licensee MDPI, Basel, Switzerland.

PubMed: MeSH publication types

  • Published Erratum

Fingerprint Dive into the research topics of 'Erratum: Tumor cell associated hyaluronan-cd44 signaling promotes pro-tumor inflammation in breast cancer (Cancers, (2020) 12, 1325, 10.3390/cancers12051325)'. Together they form a unique fingerprint.

Cite this